On the recordSeptember 12, 2017
It is time to move forward to a more flexible framework that will spur innovation, expand consumer choice, and better address potential safety concerns.
Source
congress.govEditor's note · Context
Latta advocates for updating the regulatory framework for OTC medicines to enhance innovation and safety.
Share & report
More from Bob Latta
May 14, 2024
Madam Speaker, I yield myself such time as I may consume. Madam Speaker, I rise in support of H.R. 4510, the National Telecommunications and Information Administration Reauthorization Act of 2023, which I am pleased to lead with the…
Jul 25, 2023
Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 1345) to amend the National Telecommunications and Information Administration Organization Act to establish the Office of Policy Development and Cybersecurity, and for other…
Sep 9, 2024
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 820, the Foreign Adversary Communications Transparency Act, led by the gentlewoman from New York's 21st District. The Chinese Communist Party…
May 14, 2024
Madam Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material on the bill. The SPEAKER pro tempore. Is there objection to the request of the…
Other voices in this conversation
